首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1532456

ELISA 分析仪市场 - 按类型、模式、模式、应用、最终用途 - 全球预测

ELISA Analyzers Market - By Type, Mode, Modality, Application, End-use - Global Forecast

出版日期: 2024年05月21日 | 出版商:

Global Market Insights Inc. | 英文 198 Pages | 商品交期: 2-3个工作天内

价格

简介目录

受基于患者独特基因组成、生活方式和特定健康状况的个人化医疗需求不断增长的推动，全球 ELISA 分析仪市场从 2024 年到 2032 年的复合年增长率将超过 4.2%。随着以患者为中心的医疗方法的发展，对提供精确和个人化结果的诊断工具的需求日益增长。举个例子，2024 年 5 月，Thermo Fisher Scientific 推出了一系列新型先进 ELISA 分析仪，旨在提高个人化诊断的精确度和通量。这些工具旨在改善对客製化治疗策略至关重要的生物标记的检测。

此外，诊断技术的进步提高了 ELISA 分析仪的准确性和效率，有利于更广泛的采用。糖尿病和癌症等慢性疾病的盛行率不断上升，需要定期监测和诊断，而政府对医疗基础设施的资助增加，支持在医疗设施中采用先进的诊断工具，将进一步提振市场前景。

ELISA 分析仪市场根据类型、模式、模式、应用、最终用途和区域进行细分。

在增强检测能力和提高精度的需求的推动下，到 2032 年，光栅分析仪领域将实现显着的复合年增长率。光栅技术提供卓越的灵敏度和分辨率，能够精确测量生物样品。随着研究和诊断应用变得越来越复杂，人们越来越重视获得高度准确和可靠的结果。将先进的分析技术纳入需要详细和细緻资料的应用将刺激对光栅分析仪的需求。

由于营运效率和成本效益的平衡，到 2032 年，半自动 ELISA 分析仪将获得大量市场份额。半自动化系统透过自动化重复性任务来简化工作流程，同时允许手动监督，从而提高生产力，而无需承担与全自动系统相关的高成本。这种组合对寻求提高通量和准确性同时管理预算限制的实验室很有吸引力。随着实验室和研究机构继续专注于优化流程和减少人为错误，半自动 ELISA 分析仪的采用预计将大幅增加。

由于对先进医疗保健和研究的高度重视，北美 ELISA 分析仪市场在预测期内将呈现值得注意的复合年增长率。对生物医学 RampD 的大量投资，加上强大的医疗保健基础设施，推动了对复杂诊断工具的需求。此外，慢性病盛行率的上升以及对个人化医疗的日益关注增加了对精确诊断解决方案的需求。高标准的医疗保健和支持性的监管环境有助于 ELISA 分析仪在北美地区的日益普及。

产业生态系统分析
产业影响力
- 成长动力
  - 慢性病和传染病的盛行率不断上升
  - 诊断测试的技术进步
  - 对便携式和自动化 ELISA 检测的需求不断增长
- 产业陷阱与挑战
  - 严格的监管场景
  - 设备成本高
成长潜力分析
技术景观
监管环境
定价分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按类型，2021 - 2032

主要趋势
滤光片 ELISA 分析仪
光栅 ELISA 分析仪

第 6 章：市场估计与预测：按模式，2021 - 2032

主要趋势
自动化 ELISA 分析仪
半自动 ELISA 分析仪

第 7 章：市场估计与预测：按模式，2021 - 2032 年

主要趋势
桌上型
独立式

第 8 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
免疫学
疫苗开发
药品监测及製药业
其他应用

第 9 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
生技公司
製药公司
合约研究组织 (CRO)
诊断实验室
其他最终用户

第 10 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 11 章：公司简介

Abbott Laboratories
Agilent Technologies, Inc.
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Danaher Corporation
DiaSorin S.p.A.
DYNEX Technologies
Erba Mannheim
F. Hoffmann-La Roche Ltd
Merck KGaA
PerkinElmer, Inc.
Randox Laboratories Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Tecan Group Ltd.
Thermo Fisher Scientific Inc.

简介目录

Product Code: 9569

Global ELISA Analyzers Market will witness over 4.2% CAGR from 2024 to 2032, driven by rising demand for personalized medicine based on a patient's unique genetic makeup, lifestyle, and specific health conditions. With an inclination towards patient-centric medical approaches, there is a growing need for diagnostic tools that offer precise and individualized results. Quoting an instance, in May 2024, Thermo Fisher Scientific launched a new range of advanced ELISA analyzers designed to enhance precision and throughput in personalized diagnostics. These tools aim to improve the detection of biomarkers critical for tailored treatment strategies.

Moreover, advancements in diagnostic technologies, which enhance the accuracy and efficiency of ELISA analyzers is favoring wider adoption. Rising prevalence of chronic diseases such as diabetes and cancer that necessitate regular monitoring and diagnostics, and increased government funding for healthcare infrastructure, which supports the adoption of advanced diagnostic tools in medical facilities will further bolster the market outlook.

The ELISA analyzers market is segmented based on type, mode, modality, application, end-use, and region.

The optical grating analyzers segment will record a remarkable CAGR through 2032, driven by the need for enhanced detection capabilities and improved accuracy. Optical grating technology offers superior sensitivity and resolution, enabling precise measurements of biological samples. As research and diagnostic applications become increasingly complex, there is a growing emphasis on obtaining highly accurate and reliable results. The incorporation of advanced analytical techniques for applications requiring detailed and nuanced data will fuel the demand for optical grating analyzers.

The semi-automated ELISA analyzers will procure a substantial market share by 2032, owing to the balance of operational efficiency and cost-effectiveness. Semi-automated systems streamline workflows by automating repetitive tasks while allowing for manual oversight, which enhances productivity without the high costs associated with fully automated systems. This combination appeals to laboratories seeking to improve throughput and accuracy while managing budget constraints. As laboratories and research facilities continue to focus on optimizing their processes and reducing manual errors, the adoption of semi-automated ELISA analyzers is expected to rise significantly.

North America ELISA analyzers market will exhibit a noteworthy CAGR during the forecast period, because of the strong emphasis on advanced healthcare and research. Significant investments in biomedical R&D, coupled with robust healthcare infrastructure, propel the need for sophisticated diagnostic tools. Additionally, the rising prevalence of chronic diseases and the increasing focus on personalized medicine boost the demand for precise diagnostic solutions. The high standard of medical care and supportive regulatory environment contribute to the growing adoption of ELISA analyzers across North America.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of chronic and infectious diseases
  - 3.2.1.2 Technological advancements in diagnostic testing
  - 3.2.1.3 Rising demand for portable and automated ELISA assays
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory scenario
  - 3.2.2.2 High cost of devices
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Optical filter ELISA analyzers
5.3 Optical grating ELISA analyzers

Chapter 6 Market Estimates and Forecast, By Mode, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Automated ELISA analyzers
6.3 Semi-automated ELISA analyzers

Chapter 7 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Bench-top
7.3 Stand-alone

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Immunology
8.3 Vaccine development
8.4 Drug monitoring & pharmaceutical industry
8.5 Other applications

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Biotechnology companies
9.3 Pharmaceutical companies
9.4 Contract research organizations (CROs)
9.5 Diagnostic laboratories
9.6 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa